MedTrace Logo

Tele-exercise Training Program for Long COVID

NCT07553897 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-28

No results posted yet for this study

Summary

Patients with long coronavirus disease (COVID-19) experience multisystem symptoms and reduced quality of life (QOL). Proactive interventions are needed to enhance health outcomes.To investigate the effects of a 12-week tele-exercise training program on long COVID symptoms, cardiorespiratory fitness, and QOL.

Conditions

Interventions

DEVICE

Telehealth exercise training program

Each participant received an individual exercise counselling session lasting 10-15 minutes, based on the guidelines of the American College of Sports Medicine. Participants in the home-based telehealth exercise group were provided with a mobile exercise application integrated with heart rate-monitoring clothing. The app delivers real-time heart rate feedback during each session and includes an alert system to ensure participants maintain their prescribed target heart rate based on individualized exercise prescriptions. Upon completion of each session, exercise duration and heart rate data are automatically uploaded to the medical center's cloud system via the monitoring device. An experienced nurse regularly reviewed the cloud-based data to monitor adherence. Additionally, communication between participants and researchers was facilitated through the LINE platform, enabling timely interaction and support.

BEHAVIORAL

Education and self-exercise

Each participant received an individual exercise counselling session lasting 10-15 minutes, based on the guidelines of the American College of Sports Medicine. Participants received usual outpatient care for long COVID, which included general guidance on physical activity, physician-led management of persistent symptoms (e.g., fatigue, dyspnea, and reduced exercise tolerance), and routine follow-up visits as clinically indicated.

Sponsors & Collaborators

  • Tri-Service General Hospital

    lead OTHER

Principal Investigators

  • Shang-Lin Chiang, PhD · Tri-Service General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-12
Primary Completion
2023-11-08
Completion
2023-11-22

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07553897 on ClinicalTrials.gov